ENXTPA:ORP

Stock Analysis Report

NOT FOR DISTRIBUTION
Header cover image

Executive Summary

ORPEA SA operates nursing homes, assisted-living facilities, post-acute and rehabilitation hospitals, and psychiatric hospitals. More Details


Snowflake Analysis

Moderate growth potential with poor track record.


Similar Companies

Share Price & News

How has Orpea's share price performed over time and what events caused price changes?


Latest Share Price and Events

Stable Share Price: ORP is not significantly more volatile than the rest of French stocks over the past 3 months, typically moving +/- 5% a week.

Volatility Over Time: ORP's weekly volatility (5%) has been stable over the past year.


Market Performance


7 Day Return

5.8%

ORP

2.7%

FR Healthcare

-1.0%

FR Market


1 Year Return

-2.2%

ORP

-7.1%

FR Healthcare

-4.3%

FR Market

Return vs Industry: ORP exceeded the French Healthcare industry which returned -9.1% over the past year.

Return vs Market: ORP exceeded the French Market which returned -4.6% over the past year.


Shareholder returns

ORPIndustryMarket
7 Day5.8%2.7%-1.0%
30 Day6.0%5.0%1.6%
90 Day23.6%17.4%12.8%
1 Year-2.2%-2.2%-4.8%-7.1%-2.5%-4.3%
3 Year15.7%13.4%18.6%12.7%14.6%5.1%
5 Year68.2%61.1%49.6%37.3%65.1%40.7%

Long-Term Price Volatility Vs. Market

How volatile is Orpea's share price compared to the market and industry in the last 5 years?


Simply Wall St News

Valuation

Is Orpea undervalued compared to its fair value and its price relative to the market?

38.58x

Price to Earnings (PE) ratio


Share Price vs. Fair Value

Below Fair Value: ORP (€114.85) is trading above our estimate of fair value (€39.57)

Significantly Below Fair Value: ORP is trading above our estimate of fair value.


Price To Earnings Ratio

PE vs Industry: ORP is poor value based on its PE Ratio (38.6x) compared to the FR Healthcare industry average (37x).

PE vs Market: ORP is poor value based on its PE Ratio (38.6x) compared to the French market (22.5x).


Price to Earnings Growth Ratio

PEG Ratio: ORP is poor value based on its PEG Ratio (1.9x)


Price to Book Ratio

PB vs Industry: ORP is overvalued based on its PB Ratio (2.5x) compared to the FR Healthcare industry average (2.4x).


Next Steps

Future Growth

How is Orpea forecast to perform in the next 1 to 3 years based on estimates from 11 analysts?

20.2%

Forecasted annual earnings growth


Earnings and Revenue Growth Forecasts


Analyst Future Growth Forecasts

Earnings vs Savings Rate: ORP's forecast earnings growth (20.2% per year) is above the savings rate (0.4%).

Earnings vs Market: ORP's earnings (20.2% per year) are forecast to grow slower than the French market (24.2% per year).

High Growth Earnings: earnings are expected to grow significantly over the next 3 years.

Revenue vs Market: ORP's revenue (7.3% per year) is forecast to grow faster than the French market (7% per year).

High Growth Revenue: ORP's revenue (7.3% per year) is forecast to grow slower than 20% per year.


Earnings per Share Growth Forecasts


Future Return on Equity

Future ROE: ORP's Return on Equity is forecast to be low in 3 years time (7.6%).


Next Steps

Past Performance

How has Orpea performed over the past 5 years?

8.9%

Historical annual earnings growth


Earnings and Revenue History

Quality Earnings: ORP has a large one-off gain of €77.9M impacting its June 30 2020 financial results.

Growing Profit Margin: ORP's current net profit margins (5.1%) are lower than last year (6.4%).


Past Earnings Growth Analysis

Earnings Trend: ORP's earnings have grown by 8.9% per year over the past 5 years.

Accelerating Growth: ORP's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.

Earnings vs Industry: ORP had negative earnings growth (-15.4%) over the past year, making it difficult to compare to the Healthcare industry average (-15.4%).


Return on Equity

High ROE: ORP's Return on Equity (6.3%) is considered low.


Next Steps

Financial Health

How is Orpea's financial position?


Financial Position Analysis

Short Term Liabilities: ORP's short term assets (€2.4B) do not cover its short term liabilities (€2.5B).

Long Term Liabilities: ORP's short term assets (€2.4B) do not cover its long term liabilities (€9.9B).


Debt to Equity History and Analysis

Debt Level: ORP's debt to equity ratio (235.2%) is considered high.

Reducing Debt: ORP's debt to equity ratio has increased from 176.3% to 235.2% over the past 5 years.

Debt Coverage: ORP's debt is not well covered by operating cash flow (12%).

Interest Coverage: ORP's interest payments on its debt are well covered by EBIT (3.3x coverage).


Balance Sheet


Next Steps

Dividend

What is Orpea current dividend yield, its reliability and sustainability?

1.27%

Forecast Dividend Yield


Dividend Yield vs Market

Notable Dividend: Unable to evaluate ORP's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.

High Dividend: Unable to evaluate ORP's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.


Stability and Growth of Payments

Stable Dividend: Insufficient data to determine if ORP's dividends per share have been stable in the past.

Growing Dividend: Insufficient data to determine if ORP's dividend payments have been increasing.


Current Payout to Shareholders

Dividend Coverage: ORP is not paying a notable dividend for the French market.


Future Payout to Shareholders

Future Dividend Coverage: No need to calculate the sustainability of ORP's dividend in 3 years as they are not forecast to pay a notable one for the French market.


Next Steps

Management

How experienced are the management team and are they aligned to shareholders interests?

4.0yrs

Average board tenure


CEO

Yves Le Masne (58 yo)

9.92yrs

Tenure

€2,277,960

Compensation

Mr. Yves Le Masne has been the Chief Executive Officer of Orpea SA since February 15, 2011 and served as its Chief Financial Officer and Chief Operating Officer since 2006. Previously, Mr. Le Masne served ...


CEO Compensation Analysis

Compensation vs Market: Yves's total compensation ($USD2.75M) is about average for companies of similar size in the French market ($USD2.94M).

Compensation vs Earnings: Yves's compensation has been consistent with company performance over the past year.


Board Members

NamePositionTenureCompensationOwnership
Yves Le Masne
CEO & Director9.92yrs€2.28m0.031%
€ 2.2m
Xavier Coirbay
Independent Director3.58yrs€49.00k0.00015%
€ 10.7k
Philippe Charrier
Independent Non-Executive Chairman3.83yrs€300.00k0.00062%
€ 44.1k
Thierry de Poncheville
Independent Director8.92yrs€67.00kno data
Jean-Claude Marian
Honorary Chairman3.83yrs€577.32kno data
Jean-Patrick Fortlacroix
Independent Director9.58yrs€58.00k0.00024%
€ 17.1k
Bernadette Danet-Chevallier
Independent Director6.33yrs€49.00k0.000070%
€ 5.0k
Sophie Kalaidjian
Director6yrs€13.50k0.000030%
€ 2.1k
Laure Baume
Independent Director4.08yrs€38.00k0.00031%
€ 22.0k
Joy Verle
Independent Director3.75yrs€55.00k0%
€ 0
Moritz Krautkramer
Independent Director1.83yrs€30.80k0%
€ 0
Pascale Richetta
Director1yrno datano data

4.0yrs

Average Tenure

58yo

Average Age

Experienced Board: ORP's board of directors are considered experienced (4 years average tenure).


Ownership

Who are the major shareholders and have insiders been buying or selling?


Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.


Ownership Breakdown

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.


Top Shareholders

Company Information

Orpea SA's company bio, employee growth, exchange listings and data sources


Key Information

  • Name: Orpea SA
  • Ticker: ORP
  • Exchange: ENXTPA
  • Founded: 1989
  • Industry: Health Care Facilities
  • Sector: Healthcare
  • Market Cap: €7.110b
  • Shares outstanding: 64.58m
  • Website: https://www.orpea-corp.com

Number of Employees


Location

  • Orpea SA
  • 12 rue Jean JaruEs
  • CS 10032
  • Puteaux
  • Ile-de-France
  • 92813
  • France

Listings

TickerExchangePrimary SecuritySecurity TypeCountryCurrencyListed on
ORPENXTPA (Euronext Paris)YesOrdinary SharesFREURApr 2002
OPADB (Deutsche Boerse AG)YesOrdinary SharesDEEURApr 2002
0NEXLSE (London Stock Exchange)YesOrdinary SharesGBEURApr 2002
ORPE.FOTCPK (Pink Sheets LLC)YesOrdinary SharesUSUSDApr 2002
ORPPBATS-CHIXE (BATS 'Chi-X Europe')YesOrdinary SharesGBEURApr 2002
ORP NBMV (Bolsa Mexicana de Valores)YesOrdinary SharesMXMXNApr 2002
ORRR.YOTCPK (Pink Sheets LLC)UNSPONSOR ADRUSUSDDec 2015

Biography

ORPEA SA operates nursing homes, assisted-living facilities, post-acute and rehabilitation hospitals, and psychiatric hospitals. Its nursing home facilities provide personalized support services; and logis...


Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2021/01/18 19:16
End of Day Share Price2021/01/18 00:00
Earnings2020/06/30
Annual Earnings2019/12/31


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.